Karen Linder

Karen Linder is a seasoned professional with extensive experience in the field of medicinal chemistry and medical affairs. Currently serving on the Board of Directors for TRIUMF Innovations Inc., Karen plays a pivotal role in connecting the particle accelerator laboratory with the business sector. Previous positions include Medical Science Liaison and Associate Director at Blue Earth Diagnostics, focusing on imaging agents for prostate cancer detection, and Pharma Collaborations Manager at GE Healthcare, where relationship management and oversight of international clinical trials were key responsibilities. Earlier, Karen held research roles in several prestigious organizations, including Bracco Research USA and Bristol-Myers Squibb, contributing to the development of diagnostic agents and radiochemistry. Karen holds a Ph.D. in Inorganic Chemistry from the Massachusetts Institute of Technology, as well as master's and bachelor's degrees from Northeastern University in Medicinal Chemistry and Teaching Biology, respectively.